U.S. Pharmacist eNewsletter
June 2023

Tuberculosis, Pneumonia Higher in COPD Patients Using Inhaled Corticosteroids
In a recent study published in the International Journal of Chronic Obstructive Pulmonary Disease, researchers conducted a retrospective observational study and sought to obtain real-world data by investigating the impact of inhaled corticosteroids on the prognosis of Asian patients with chronic obstructive pulmonary disease (COPD). Learn more about the results of this study.


Variant Lung Cells in Patients With Idiopathic Pulmonary Fibrosis
Previous research has established that although the mechanisms initiating idiopathic pulmonary fibrosis (IPF) remain unclear, it is believed that IPF may develop from recurrent, subclinical lung injury that imparts changes to epithelial and stromal cells, which compromise lung repair and promote fibrosis. Recently, researchers sought to understand more about IPF and the etiology of this disease with high mortality rates. Read more.

Dexamethasone Correlated With Decreased Mortality in COVID-19 Patients
Previous research has demonstrated the contrasting effects of systemic corticosteroids, including dexamethasone, in hospitalized patients with COVID-19, with limited descriptions of important patient subgroups. In a recent study, researchers indicated that the use of dexamethasone early on diminished mortality risk and discharge to hospice care among patients receiving supplemental oxygen or mechanical ventilation and/or extracorporeal membrane oxygenation. Read more.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App